DK116128B - Fremgangsmåde til fremstilling af terapeutisk virksomme 17α-(alkanoyloxy eller cycloalkanoyloxy)-21-(alkanoyloxy eller cycloalkanoyloxy)-16β-methyl-9α-halogen-11β-hydroxy-Δ<1,4>-pregnadien-3,20-dioner. - Google Patents
Fremgangsmåde til fremstilling af terapeutisk virksomme 17α-(alkanoyloxy eller cycloalkanoyloxy)-21-(alkanoyloxy eller cycloalkanoyloxy)-16β-methyl-9α-halogen-11β-hydroxy-Δ<1,4>-pregnadien-3,20-dioner.Info
- Publication number
- DK116128B DK116128B DK291164AA DK291164A DK116128B DK 116128 B DK116128 B DK 116128B DK 291164A A DK291164A A DK 291164AA DK 291164 A DK291164 A DK 291164A DK 116128 B DK116128 B DK 116128B
- Authority
- DK
- Denmark
- Prior art keywords
- cycloalkanoyloxy
- alkanoyloxy
- pregnadiene
- diones
- hydroxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Insulated Conductors (AREA)
- Combinations Of Kitchen Furniture (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB23223/63A GB1047518A (en) | 1963-06-11 | 1963-06-11 | 17ª-monoesters of 11,17,21-trihydroxy steroid compounds |
| GB362364 | 1964-01-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK116128B true DK116128B (da) | 1969-12-15 |
Family
ID=26238483
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK291064AA DK116205B (da) | 1963-06-11 | 1964-06-10 | Analogifremgangsmåde til fremstilling af 17α-alkanoyloxy-9α-halogen-16β-methyl-11β,21-dihydroxy-Δ<1,4>-pregnadien-3,20-dioner. |
| DK291164AA DK116128B (da) | 1963-06-11 | 1964-06-10 | Fremgangsmåde til fremstilling af terapeutisk virksomme 17α-(alkanoyloxy eller cycloalkanoyloxy)-21-(alkanoyloxy eller cycloalkanoyloxy)-16β-methyl-9α-halogen-11β-hydroxy-Δ<1,4>-pregnadien-3,20-dioner. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK291064AA DK116205B (da) | 1963-06-11 | 1964-06-10 | Analogifremgangsmåde til fremstilling af 17α-alkanoyloxy-9α-halogen-16β-methyl-11β,21-dihydroxy-Δ<1,4>-pregnadien-3,20-dioner. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US3312590A (da) |
| BE (2) | BE649170A (da) |
| BR (2) | BR6459937D0 (da) |
| CH (2) | CH450410A (da) |
| CY (1) | CY544A (da) |
| DE (2) | DE1443957B1 (da) |
| DK (2) | DK116205B (da) |
| ES (2) | ES300814A1 (da) |
| FR (1) | FR4548M (da) |
| GB (1) | GB1047518A (da) |
| MY (1) | MY7000131A (da) |
| NL (2) | NL142157B (da) |
| NO (2) | NO125532B (da) |
| SE (2) | SE313562B (da) |
Families Citing this family (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3475466A (en) * | 1965-08-30 | 1969-10-28 | Schering Corp | Novel 17,21-diesters of 16alpha-methyl-9alpha,11beta-dichloro-1,4- pregnadienes |
| US3422193A (en) * | 1966-08-11 | 1969-01-14 | Schering Corp | 17-mono esters of corticoids |
| IT1061787B (it) * | 1967-03-01 | 1983-04-30 | Vismara Francesco Spa | Miglioramenti relativi alla preparazione di 17 benzoato di betametazone |
| GB1281689A (en) * | 1968-10-14 | 1972-07-12 | Glaxo Lab Ltd | Steroid 21-phosphates |
| US3694471A (en) * | 1970-06-08 | 1972-09-26 | Warner Lambert Pharmaceutical | 17-valerate ester of 6{60 ,9{60 -difluorohydrocortisone, its compositions and use as an anti-inflammatory agent |
| DK135267A (da) * | 1971-02-25 | |||
| US3789121A (en) * | 1971-11-26 | 1974-01-29 | Warner Lambert Co | 17{60 ,21-orthobutyrates of 6{60 , 9{60 -difluoro-hydrocortisone and 6{60 , 9{60 -difluoroprednisolone, compositions containing same and the use thereof as anti-inflammatory agents |
| GB1429184A (en) * | 1972-04-20 | 1976-03-24 | Allen & Hanburys Ltd | Physically anti-inflammatory steroids for use in aerosols |
| US4044126A (en) * | 1972-04-20 | 1977-08-23 | Allen & Hanburys Limited | Steroidal aerosol compositions and process for the preparation thereof |
| SE418294B (sv) * | 1974-03-27 | 1981-05-18 | Plurichemie Anstalt | Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester |
| US4018918A (en) * | 1975-05-20 | 1977-04-19 | The Upjohn Company | Topical clindamycin preparations |
| DE2645104C2 (de) * | 1976-10-04 | 1986-04-24 | Schering AG, 1000 Berlin und 4709 Bergkamen | 11β-Hydroxy-1,4,8-pregnatrien-3,20-dion-Derivate und Verfahren zu ihrer Herstellung |
| US4070462A (en) * | 1976-10-26 | 1978-01-24 | Schering Corporation | Steroid ointment |
| JPS6040439B2 (ja) * | 1978-03-29 | 1985-09-11 | 大正製薬株式会社 | ヒドロコルチゾン誘導体 |
| DE3068965D1 (en) * | 1979-11-16 | 1984-09-20 | Sterosynt Ltd | 6-alpha-fluoro-16-methyl-prednisolone-17,21 diesters and pharmaceutical compositions containing them |
| US4350690A (en) * | 1980-10-27 | 1982-09-21 | Cressington Investments Ltd. | Steroid composition |
| US4346086A (en) * | 1981-06-09 | 1982-08-24 | Beiersdorf Aktiengesellschaft | Corticosteroid-containing cream |
| IL66432A0 (en) * | 1981-08-04 | 1982-12-31 | Plurichemie Anstalt | Process for the preparation of steroidal esters |
| DE3133081A1 (de) * | 1981-08-18 | 1983-03-10 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue 6(alpha)-methylprednisolon-derivate, ihre herstellung und verwendung |
| FR2515041A1 (fr) * | 1981-10-26 | 1983-04-29 | Besins Jean | Medicament a base de progesterone pour le traitement des affections mammaires |
| EP0095894A3 (en) * | 1982-05-31 | 1985-01-02 | Ohta Seiyaku Kabushiki Kaisha. | 6 alpha-methylprednisolone derivatives |
| DE3227312A1 (de) * | 1982-07-19 | 1984-01-19 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung |
| DE3243482A1 (de) * | 1982-11-22 | 1984-05-24 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue 6(alpha)-methylkortikoide, ihre herstellung und verwendung |
| US4489070A (en) * | 1983-05-13 | 1984-12-18 | Schering Corporation | Betamethasone dipropionate cream |
| US4482539A (en) * | 1983-05-13 | 1984-11-13 | Schering Corporation | Betamethasone dipropionate cream |
| DE3400188A1 (de) * | 1984-01-02 | 1985-07-11 | Schering AG, Berlin und Bergkamen, 1000 Berlin | Neue 6(alpha),16(alpha)-dimethylkortikoide |
| PT78973A (en) * | 1984-07-25 | 1984-08-01 | Joao Emerico Villax | New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid |
| SK280967B6 (sk) | 1990-03-02 | 2000-10-09 | Glaxo Group Limited | Inhalačný prístroj |
| US6536427B2 (en) | 1990-03-02 | 2003-03-25 | Glaxo Group Limited | Inhalation device |
| MY105368A (en) * | 1990-03-02 | 1994-09-30 | Glaxo Group Ltd | Inhalation device. |
| US6777399B2 (en) * | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| US6759398B2 (en) * | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
| GB0019172D0 (en) * | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
| KR20030071751A (ko) * | 2000-08-05 | 2003-09-06 | 글락소 그룹 리미티드 | 항염증제로서의 17.베타.-카르보티오에이트17.알파.-아릴카르보닐옥실록시 안드로스탄 유도체 |
| US6858596B2 (en) * | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
| PL366937A1 (en) * | 2001-04-30 | 2005-02-07 | Glaxo Group Limited | Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
| DE60227254D1 (de) * | 2001-06-12 | 2008-08-07 | Glaxo Group Ltd | Neue anti inflammatorische 17.alpha.-heterozyklische ester von 17.beta.-carbothioat androstan derivativen |
| AU2002356759A1 (en) * | 2001-12-01 | 2003-06-17 | Glaxo Group Limited | 17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents |
| US20050175545A1 (en) * | 2002-02-04 | 2005-08-11 | Keith Biggadike | Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
| GB0202635D0 (en) * | 2002-02-05 | 2002-03-20 | Glaxo Wellcome Mfg Pte Ltd | Formulation containing novel anti-inflammatory androstane derivative |
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| NZ545748A (en) * | 2003-08-29 | 2010-03-26 | Ranbaxy Lab Ltd | Isoxazoline derivatives as inhibitors of phosphodiesterase type-IV |
| US20070259874A1 (en) * | 2003-11-26 | 2007-11-08 | Palle Venkata P | Phosphodiesterase Inhibitors |
| US20080009535A1 (en) * | 2004-08-30 | 2008-01-10 | Sarala Balachandran | Inhibitors of phosphodiesterase type-IV |
| GB0507165D0 (en) * | 2005-04-08 | 2005-05-18 | Glaxo Group Ltd | Novel crystalline pharmaceutical product |
| EP1934219A1 (en) | 2005-09-16 | 2008-06-25 | Ranbaxy Laboratories Limited | Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
| BRPI0617674A2 (pt) | 2005-10-19 | 2011-08-02 | Ranbaxy Lab Ltd | composições farmacêuticas e seus usos |
| WO2007045980A1 (en) * | 2005-10-19 | 2007-04-26 | Ranbaxy Laboratories Limited | Compositions of phosphodiesterase type iv inhibitors |
| GB0615108D0 (en) * | 2006-07-28 | 2006-09-06 | Glaxo Group Ltd | Novel formulations |
| CN101616901A (zh) * | 2006-09-22 | 2009-12-30 | 兰贝克赛实验室有限公司 | Iv型磷酸二酯酶的抑制剂 |
| WO2008035316A2 (en) * | 2006-09-22 | 2008-03-27 | Ranbaxy Laboratories Limited | Phosphodiesterase inhibitors |
| US20080207659A1 (en) * | 2007-02-15 | 2008-08-28 | Asit Kumar Chakraborti | Inhibitors of phosphodiesterase type 4 |
| CN101801376A (zh) * | 2007-03-14 | 2010-08-11 | 兰贝克赛实验室有限公司 | 用作磷酸二酯酶抑制剂的吡唑并(3,4-b)吡啶衍生物 |
| WO2008111009A1 (en) * | 2007-03-14 | 2008-09-18 | Ranbaxy Laboratories Limited | Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors |
| US8796248B2 (en) | 2007-10-05 | 2014-08-05 | Nektar Therapeutics | Oligomer-corticosteroid conjugates |
| EP2111861A1 (en) | 2008-04-21 | 2009-10-28 | Ranbaxy Laboratories Limited | Compositions of phosphodiesterase type IV inhibitors |
| CN112358522B (zh) * | 2020-05-18 | 2021-11-16 | 河南利华制药有限公司 | 一种倍他米松二丙酸酯的精制方法及倍他米松二丙酸酯 |
| CN111944002A (zh) * | 2020-07-29 | 2020-11-17 | 河南利华制药有限公司 | 一种倍氯米松二丙酸酯中间体及制备方法 |
| CN116023425B (zh) * | 2023-03-28 | 2023-06-20 | 南京师范大学 | 曲安西龙衍生物及其医药用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3147249A (en) * | 1961-06-13 | 1964-09-01 | Vismara Francesco Spa | 17alpha, 21-substituted methylenedioxy steroids and methods therefor |
| DE1195748B (de) * | 1961-06-24 | 1965-07-01 | Vismara Francesco Spa | Verfahren zur Herstellung von 1'-substituierten 17alpha, 21-(1'-Alkoxy)-methylendioxysterioden |
-
1963
- 1963-06-11 GB GB23223/63A patent/GB1047518A/en not_active Expired
-
1964
- 1964-06-09 CH CH752364A patent/CH450410A/de unknown
- 1964-06-09 CH CH752464A patent/CH457422A/de unknown
- 1964-06-09 US US373837A patent/US3312590A/en not_active Expired - Lifetime
- 1964-06-10 DK DK291064AA patent/DK116205B/da unknown
- 1964-06-10 NO NO153601A patent/NO125532B/no unknown
- 1964-06-10 SE SE7049/64A patent/SE313562B/xx unknown
- 1964-06-10 ES ES300814A patent/ES300814A1/es not_active Expired
- 1964-06-10 DK DK291164AA patent/DK116128B/da unknown
- 1964-06-10 NO NO153602A patent/NO125533B/no unknown
- 1964-06-10 FR FR977701A patent/FR4548M/fr not_active Expired
- 1964-06-10 DE DE19641443957 patent/DE1443957B1/de active Pending
- 1964-06-10 SE SE7048/64A patent/SE320066B/xx unknown
- 1964-06-10 ES ES300811A patent/ES300811A1/es not_active Expired
- 1964-06-10 DE DE19641443958 patent/DE1443958B1/de active Pending
- 1964-06-11 BE BE649170D patent/BE649170A/xx unknown
- 1964-06-11 NL NL646406614A patent/NL142157B/xx not_active IP Right Cessation
- 1964-06-11 BR BR159937/64A patent/BR6459937D0/pt unknown
- 1964-06-11 BE BE649171D patent/BE649171A/xx unknown
- 1964-06-11 BR BR159936/64A patent/BR6459936D0/pt unknown
- 1964-06-11 NL NL646406615A patent/NL141378B/xx not_active IP Right Cessation
-
1970
- 1970-07-02 CY CY54470A patent/CY544A/xx unknown
- 1970-12-31 MY MY1970131A patent/MY7000131A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR6459936D0 (pt) | 1973-08-02 |
| NL141378B (nl) | 1974-03-15 |
| DK116205B (da) | 1969-12-22 |
| GB1047518A (en) | 1966-11-02 |
| NO125532B (da) | 1972-09-25 |
| NL6406615A (da) | 1964-12-14 |
| US3312590A (en) | 1967-04-04 |
| BR6459937D0 (pt) | 1973-08-07 |
| CH450410A (de) | 1968-01-31 |
| NO125533B (da) | 1972-09-25 |
| ES300811A1 (es) | 1962-12-16 |
| BE649171A (da) | 1964-12-11 |
| SE320066B (da) | 1970-02-02 |
| ES300814A1 (es) | 1964-12-01 |
| SE313562B (da) | 1969-08-18 |
| DE1443958B1 (de) | 1970-01-02 |
| NL142157B (nl) | 1974-05-15 |
| BE649170A (da) | 1964-12-11 |
| FR4548M (da) | 1966-11-02 |
| CY544A (en) | 1970-07-02 |
| DE1443957B1 (de) | 1970-01-02 |
| NL6406614A (da) | 1964-12-14 |
| CH457422A (de) | 1968-06-15 |
| MY7000131A (en) | 1970-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK116128B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomme 17α-(alkanoyloxy eller cycloalkanoyloxy)-21-(alkanoyloxy eller cycloalkanoyloxy)-16β-methyl-9α-halogen-11β-hydroxy-Δ<1,4>-pregnadien-3,20-dioner. | |
| DK129835B (da) | Analogifremgangsmåde til fremstilling af 2-chlor-6α-fluor-16α-methyl-pregna-1,4-dien-3,20-dioner. | |
| DK116870B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 11β,21-dihydroxy-3,20-dioxo- eller 21-hydroxy-3,11,20-trioxo-pregna-1,4-dien-(17α 16&alpha,-d)-2'metyloxazoliner eller 21-estere deraf. | |
| DK117563B (da) | Analogifremgangsmåde til fremstilling af 17α,21-(1'-alkyl-1'-alkoxy-methylendioxy)-11β-hydroxy-9-α-halogen-16β-methyl-1,4-pregnadien-3,20-dioner. | |
| DK120190B (da) | Analogifremgangsmåde til fremstilling af terapeutisk aktive 17-estere af 9α,11β-dihalogen-16α-alkyl-Δ<1,4>-pregnadien-17α,21-diol-3,20-dioner. | |
| DK120337B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive 3-keto-6-halogen-9β10α-Δ<4,6>-steroiddiener af androstan- eller pregnanrækken. | |
| DK114690B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomt 17α-ethinyl-Δ<1,3,5(10)>-østratrien-3,16α,17β-triol eller estere eller ethere deraf. | |
| DK120701B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 17β-tetrahydropyranylethere af Δ<1,3,5(10)>-østratrien-3-ol-eller 3-ethere eller 3-estere deraf. | |
| DK126111B (da) | Fremgangsmåde til fremstilling af Δ<5,10>-steroider med cyclopentanoperhydrophenanthrenstruktur. | |
| DK112235B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomme 21-dicyclohexylmethylcarbonater af 21-hydroxy-Δ<4>-pregnen-17α-ol-3,20-dioner. | |
| DK114060B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomme 1,2β-metylensteroider af androstan- eller 9-norandrostanrækken. | |
| DK113146B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomme 6-halogen-1α,2α-methylen-16α-methyl-&Delta<4,6>-pregnadien-17α-ol-3,20-dioner eller deres 17-estere. | |
| DK116658B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ<5>-østrener. | |
| DK124539B (da) | Fremgangsmåde til fremstilling af 6-hydroxy-3-keto-Δ<1,4>-steroider af pregnan- eller androstanrækken. | |
| DK122452B (da) | Analogifremgangsmåde til fremstilling af 21-estere af 6α-halogen-16α-methyl-Δ<1,4>-pregnadien-11β,21-diol-3,20-dioner. | |
| DK113640B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 9α,11β-dihalogen-pregna-1,4-dien-[17α,16α-d]-oxazolin-3,20-dioner. | |
| DK132121B (da) | Fremgangsmåde til fremstilling af 17alfa-hydroxypregna-4,9(11)-dien-3,20-dion. | |
| DK111615B (da) | Fremgangsmåde til fremstilling af 6α,9α-difluor-16α-metyl-Δ<1,4>-pregnadien-11β,21-diol-3,20-dion eller estere deraf. | |
| DK118556B (da) | Analogifremgangsmåde til fremstilling af 16α-methyl-9α-chlor-Δ<1,4>-pregnadien-11β,21-diol-3,20-dioner eller 21-estere deraf. | |
| DK123768B (da) | Analogifremgangsmåde til fremstilling af terapeutisk aktive 6-halogeno-9β, 10α-Δ<1,4>, Δ<4,6>- eller Δ <1,4,6>- pregnen-3,20-dioner eller tilsvarende 3-alkoxy-Δ<3,5>- derivater deraf. | |
| DK114832B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive 3β-hydroxy-16α-alkyl-δ<4>-pregnenderivater eller estere deraf. | |
| DK123767B (da) | Fremgangsmåde til fremstilling af diastereomere 2β,3β,14α,22,25-pentahydroxy-Δ<7>-cholesten-6-oner eller blandinger deraf. | |
| DK118716B (da) | Analogifremgangsmåde til fremstilling af terapeutisk aktive 6α-methyl-16-methylen-Δ<4>-ostren-17β-oler eller estere deraf. | |
| DK112380B (da) | Fremgangsmåde til fremstilling af 6-methyl-3-oxo-Δ<4,7>-steroider af pregnanrækken. | |
| DK112168B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomme 17-estere af 16α-halogen-6α-methyl-17α-hydroxy-4-pregnen-3,20-dioner. |